Senseonics Holdings (SENS) Cash from Operations Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -99.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.16% |
| Dec 31, 2025 | -26.11% |
| Sep 30, 2025 | -6.76% |
| Jun 30, 2025 | 16.83% |
| Mar 31, 2025 | 20.64% |
| Dec 31, 2024 | 5.45% |
| Sep 30, 2024 | 14.19% |
| Jun 30, 2024 | 38.04% |
| Mar 31, 2024 | -2.09% |
| Dec 31, 2023 | 13.34% |
| Sep 30, 2023 | -18.38% |
| Jun 30, 2023 | -26.81% |
| Mar 31, 2023 | 1.54% |
| Dec 31, 2022 | -47.31% |
| Sep 30, 2022 | -5.16% |
| Jun 30, 2022 | -0.23% |
| Mar 31, 2022 | -23.99% |
| Dec 31, 2021 | -43.10% |
| Sep 30, 2021 | -3.52% |
| Jun 30, 2021 | 15.42% |
| Mar 31, 2021 | 44.03% |
| Dec 31, 2020 | 76.13% |
| Sep 30, 2020 | 62.40% |
| Jun 30, 2020 | 53.14% |
| Mar 31, 2020 | 3.66% |
| Dec 31, 2019 | -45.99% |
| Sep 30, 2019 | -33.30% |
| Jun 30, 2019 | -79.70% |
| Mar 31, 2019 | -47.09% |
| Dec 31, 2018 | -45.34% |
| Sep 30, 2018 | -75.29% |
| Jun 30, 2018 | -57.87% |
| Mar 31, 2018 | -76.47% |
| Dec 31, 2017 | -59.40% |
| Sep 30, 2017 | -46.34% |
| Jun 30, 2017 | -26.52% |
| Mar 31, 2017 | -56.34% |
| Sep 30, 2016 | -127,143.86% |
| Jun 30, 2016 | 5.71% |
| Mar 31, 2016 | -47.63% |
| Sep 30, 2015 | -46.73% |